A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Teva Pharmaceuticals

Status: Completed

Conditions: Malignant Melanoma; Parkinson's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00203008

EP002

Details and patient eligibility

About

Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

Enrollment: 2,106 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment

Exclusion criteria

unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

Trial design

2,106 participants in 1 patient group

Observational procedure

Description:

Patients will be examined and any suspicious skin abnormalities will be biopsied